Ivabradine 7.5mg orally
Drugadditive use to the standard medication with bisoprolol
Other names: ivabradine is marketed as Procoralan
NCT Number: NCT02764970
Out-patients scheduled for coronary computer tomographic angiography (CCTA) were screened regarding their baseline heart rate. If heart rate was > 75, patients were pretreated with 10mg bisoprolol (group 1) or 10mg bisoprolol plus 7.5mg ivabradine (group 2) to reduce heart rate one our before CCTA was performed.
Heart rate, additional use of i.v. bradycardic agents, motion artefacts, radiation dose and drug tolerance was monitored.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Aim of the study is to evaluate if ivabradine, an inhibitor of the funny channel (If), in addition to bisoprolol is effective in lowering heart rate before coronary computer tomographic angiography (CCTA) if administered orally one hour before the scan.
Out-patients of a single radiology center are included in this retrospective analysis. All patients are referred to an ambulant CCTA. All scans are performed with a Siemens Somatom Sensation Cardiac 64 Computer Tomograph and analyzed with Siemens Syngo Plaza software. Patients with an initial heart rate of ≥ 75 bpm are either pretreated with bisoprolol 10mg p.o. alone (group 1) or a combination of bisoprolol 10mg and ivabradine 7.5mg p.o. (group 2) one hour before the CT scan.
The change in treatment from bisoprolol only to the combination of bisoprolol and ivabradine was introduced as a change in standard treatment independent of the study. The study was only plannend and performed as a retrospective analysis after the last patient included into the analysis was already treated.
Additional betablocker is administered intravenously right before the scan if heart rate remains elevated.
The hypothesis is that the addition of ivabradine to bisoprolol results in a pronounced heart rate reduction. This heart rate reduction will lead to a reduced need of i.v. bradicardic drug use, a reduction in motion artifacts and a reduced radiation dose to to a higher rate of flash sequences.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
additive use to the standard medication with bisoprolol
Other names: ivabradine is marketed as Procoralan
Time frame: intraoperative
number of beats per minute
Time frame: time from first ECG in the CT-room to start of CT scan (average of 10 minutes)
measured in mg metoprolol used
Time frame: intraoperative
as calculated in mSv
Time frame: intraoperative
Counted linear misalignments in the ap projection
Medical University of Graz
Other
Heart Rate Reducing Therapy With Ivabradine and Bisoprolol Before Coronary Computer Tomographic Angiography in Ambulant Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06540079
Arrhythmia, Sinus, Arrhythmias, Cardiac
Phoenix, Arizona, United States
View Trial DetailsNCT05345925
A-V Block, Arrhythmias, Cardiac
Krakow, Poland
View Trial DetailsNCT04463121
Arrhythmias, Cardiac, Bradycardia
Prague, Czechia
View Trial DetailsNCT02083952
Apnea, Arrhythmias, Cardiac
Ridgewood, New Jersey, United States
View Trial Details